Home   Chapter Home   Jobs   Conferences   Fellowships   Books

 

 

 

Soft Tissue Tumors Part 3

Muscle, Vascular, Nerve, Other

Leiomyosarcoma-general

 

Author: Nat Pernick, M.D, PathologyOutlines.com, Inc.

Revised: 12 August 2009, last major update - August 2009

Copyright: (c) 2002-2009, PathologyOutlines.com, Inc.

 

Leiomyosarcoma: general, cutaneous, epithelioid, myxoid, pleomorphic, rhabdoid features

 

Definition

=========================================================================

● Smooth muscle tumor with atypia plus either mitotic activity, tumor cell necrosis or size > 10 cm

● 10% of adult soft tissue sarcomas

● Variants are described separately above

 

Epidemiology

=========================================================================

Skin/subcutis: see cutaneous variants above; better survival than retroperitoneal tumors

Retroperitoneum: third most common retroperitoneal sarcoma after liposarcoma and MFH; usually women, 5 year survival is only 29%

Immunocompromised patients: associated with EBV in HIV patients; may be multifocal

 

Sites

=========================================================================

● Usually extremities

● Often arises from large vessels (AJSP 2002;26:14), most commonly inferior vena cava, saphenous vein, femoral vein, pulmonary artery, femoral artery

● Also occurs in retroperitoneum, superficial or deep soft tissues

 

Case reports

=========================================================================

● 26 year old man with EBV+ tumor after heart transplantation (AJSP 2000;24:614)

● 54 year old man with tumor of inferior vena cava (Archives 2003;127:e423)

69 year old man with tumor of internal jugular vein (World J Surg Oncol 2008;6:113)

 

Treatment and prognosis

=========================================================================

● Excision with clear margins (enucleation is inadequate treatment)

● Often recurs locally or metastasizes

● Lung is common site of metastasis, lymph nodes are uncommon site

Poor prognostic factors: retroperitoneal, mesenteric or other deep location, size > 5 cm, age > 62 years, high grade, tumor disruption by prior incisional biopsy or incomplete excision (Cancer 2007;109:282), possibly nuclear c-myc expression (Mod Pathol 2009 Jul 24 [Epub ahead of print])

● In extremities, poor prognostic factors are large size and high mitotic rate; best treatment is wide surgical excision plus adjuvant radiation therapy (Eur J Surg Oncol 2004;30:565)

 

Clinical images

=========================================================================

 

 

12 cm tibial tumor

 

Gross description

=========================================================================

● Large, soft, often necrosis, hemorrhage and cystic degeneration

● May project into lumen of major vessels or be intramural

 

Gross images

=========================================================================

 

          

Recurrent tumor         Fusiform tumor of arm       Tumor of popliteal vein

                                                                        with cystic cavity

 

Images:  leg tumor #1#2retroperitoneal tumor;  thigh tumornecrotic tumor within skeletal muscle    

 

Micro description

=========================================================================

● Fascicular growth pattern (bundles intersect at right angles)

● Tumor cells merge with blood vessel walls

● Palisading of spindle cells with eosinophilic fibrillary cytoplasm, focal granularity

● Nuclei are cigar-shaped and blunt-ended with variable atypia, often with cytoplasmic vacuoles at both ends of nuclei (unlike neural lesions)

● Mitotic figures are common

● May have hemangiopericytoma-like vasculature, nuclear palisading, myxoid change, osteoclast-like giant cells

● Often infiltrates into adjacent tissue
● See also variants above

 

Malignant criteria by site

=========================================================================

Soft tissue: 1-2 MF/10 HPF and deep

Skin/subcutaneous: 2 MF/10 HPF is definitive, 1 MF/10 HPF if consistent in all fields

Retroperitoneum: 5 MF/10 HPF is definitive, or 1-4 MF/10 HPF plus necrosis plus size > 7.5 cm

Vascular: 1-4 MF/10 HPF plus large size plus necrosis

● Diagnosis as tumor of uncertain malignant potential (UMP) if mitotic figures are fewer than above or focal

 

Micro images

=========================================================================

 

                                                                 

Malignant based on                                           Pleomorphism and smooth

low power pleomorphism                                muscle differentiation are evident

 

 

                                  

Markedly pleomorphic, little evidence          Multinucleated giant cells

of smooth muscle differentiation

 

 

                                          

Tumor of inferior vena cava - cytology,        Intravenous tumor

H&E and smooth muscle actin

 

 

H&E and h-caldesmon

 

 

                                                                        

Retroperitoneum: smooth muscle morphology         Marked pleomorphism    

                                                                                                and no identifiable smooth muscle

 

 

                                                                        

Uncertain malignant potential: 8 cm retroperitoneal tumor with bland cells and < 1 MF/10 HPF

 

 

                                     

Tumor cells are intimately associated with vessels:                               Hemangiopericytoma-like

H&E and smooth muscle actin                                                                       growth pattern

 

 

                      

Hereditary retinoblastoma patients:                    Coagulative tumor         MIB index is 35-40%

                                                                                       cell necrosis

 

Cytology description

=========================================================================

● Fascicles with an mixture of dispersed cells or stripped nuclei

● Most cells are spindled with elongated, blunt-ended, segmented or fusiform nuclei or round/polygonal with round or indented nuclei

● Also pleomorphic cells, occasionally intranuclear vacuoles, mitoses and osteoclast-like giant cells (Diagn Cytopathol 2006;34:597)

 

Positive stains

=========================================================================

● HHF-35 (90%), alpha-smooth muscle actin (90%), vimentin, desmin (75%) (Cancer 2009 Jul 22 [Epub ahead of print])

● H-caldesmon (Am J Clin Pathol 2000;113:663)

● PTAH (stains myofibrils), keratin (30%), ER (usually in uterine and female retroperitoneal tumors), S100 (occasionally weak staining), EMA (may be focal)

 

Negative stains

=========================================================================

● CD117

 

Electron microscopy

=========================================================================

● Some smooth muscle features, including cytoplasmic filaments with focal densities (also present in myofibroblasts), pinocytotic vesicles, thick basal lamina

 

Molecular / cytogenetics

=========================================================================

● Often complex karyotypes with no consistent aberrations

 

Differential Diagnoses

=========================================================================

● Leiomyoma - no/rare mitotic activity, no/minimal atypia, small size, no hemorrhage, no necrosis

● Dedifferentiated liposarcoma - usually trunk, better prognosis, well differentiated component present, MDM2 and CDK4 amplification (AJSP 2007;31:1557)

 

End of Soft Tissue Tumors Part 3 - Muscle, Vascular, Nerve, Other > Leiomyosarcoma

 

 

 

This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must also be interpreted in the context of a patient's clinical data using reasonable medical judgment.  This website should not be used as a substitute for the advice of a licensed physician.

 

All information on this website is protected by Copyright, (c) 2001-2009, PathologyOutlines.com, Inc.  Information from third parties may also be protected by copyright.  Please contact us at copyrightPathOut@gmail.com with any questions.